Natural catalytic antibodies in norm and in autoimmune diseases

Autoimmune Diseases: Symptoms, Diagnosis and Treatment

Volumn , Issue , 2010, Pages 1-106

  Nevinsky, G A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85058764229     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (279)

1. Pauling, L. (1946). Molecular basis of biological specificity. Chem. Eng. News, 24, 13751-377.
2. Jencks, W. (1969). Catalysis in chemistry and enzymology. New York: McGraw-Hill.
3. Schochetman, G.& Massey, R. (1985). International Patent no. W085/02414.
4. Pollack, S. J., Jacobs, J. W.& Schultz, P. G. (1986). Selective chemical catalysis by an antibody. Science, 234, 1570-1573.
5. Tramontano, A., Janda, K. D.& Lerner, R. A. (1986). Catalytic antibodies. Science, 234, 1566-1570.
6. Tramontano, A., Janda, K. D.& Lerner, R. A. (1986). Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen. Proc. Natl. Acad. Sci. USA, 83, 6736-6740.
7. Lerner, R. A.& Tramontano, A. (1987). Antibodies as enzymes. Trends in Bioch. Sci., 12, 427-438.
8. Benkovic, S. J. (1992) Catalytic antibodies. Annu. Rev. Biochem., 61, 29-54.
9. Stewart, J. D.& Benkovic, S. J. (1993). Recent developments in catalytic antibodies. Int. Rev. Immunol., 10, 229-240.
10. Martin, A. B.& Schultz, P. G. (1999). Opportunities at the interface of chemistry and biology. Trends Cell Biol., 9, 24-28.
11. Nevinsky, G. A., Semenov, D. V.& Buneva, V. N. (2000). Catalytic antibodies (abzymes) induced by stable transition-state analogs. Biochemistry (Moscow), 65, 1233-1244.
12. Tanaka, F. (2002). Catalytic antibodies as designer proteases and esterases. Chem Rev., 102, 4885-4906.
13. Deng S. X., de Prada, P.& Landry, D. W. (2002). Anticocaine catalytic antibodies. J. Immunol. Methods, 269, 299-310.
14. Dias, S., Jovic, F., Renard, P. Y., Taran, F., Créminon, C., Mioskowski, C.& Grassi, J. (2002). Immunologically driven chemical engineering of antibodies for catalytic activity. J. Immunol. Methods, 269, 81-98.
15. Tanaka, F.& Barbas, C. F. 3rd. (2002). Reactive immunization: a unique approach to catalytic antibodies. J. Immunol. Methods, 269, 67-79.
16. Keinan, E. E. (Eds.) (2005). Catalytic antibodies, pp. 1-586. Weinheim: Wiley-VCH Verlag GmbH and Co. KgaA.
17. Paul, S., Volle, D. J., Beach, C. M., Johnson, D. R., Powell, M. J.& Massey, R. J. (1989). Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science, 244, 1158-1162.
18. Shuster, A. M., Gololobov, G. V. Kvashuk, O. A. Bogomolova, A. E. Smirnov, I. V&. Gabibov, A. G. (1992). DNA hydrolyzing autoantibodies. Science, 256, 665-667.
19. Buneva, V. N., Andrievskaia, O. A., Romannikova, I. V., Gololobov, G. V., Iadav, R. P., Iamkovoi, V. I.& Nevinskii, G. A. (1994). Interaction of catalytically active antibodies with oligoribonucleotides. Mol. Biol. (Moscow) 28, 738-743.
20. Suzuki, H. (1994). Recent advances in abzyme studies. J. Biochem., 115, 623-633.
21. Tramontano, A., Gololobov, G.& Paul, S. (2000). Proteolytic antibodies: origins, selection and induction. Chem. Immunol., 77, 1-17.
22. Gololobov, G., Tramontano, А.& Paul, S. (2000). Nucleophilic proteolytic antibodies. Appl. Biochem. Biotechnol., 83, 221-231.
23. Nevinsky, G. A., Kanyshkova, T. G.& Buneva, V. N. (2000). Natural catalytic antibodies (abzymes) in normalcy and pathology. Biochemistry (Moscow), 65, 1245-1255.
24. Nevinsky, G. A.& Buneva, V. N. (2002). Human catalytic RNA- and DNAhydrolyzing antibodies. J. Immunol. Methods, 269, 235-245.
25. Nevinsky, G. A., Favorova, O. O.& Buneva, V. N. (2002). Natural Catalytic Antibodies - New Characters in the Protein Repertoire. In E. Golemis (Eds.), Proteinprotein interactions; a molecular cloning manual, pp. 532-534. New York, Cold Spring Harbor: Cold Spring Harbor Lab. Press.
26. Nevinsky, G. A.& Buneva, V. N. (2003). Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J. Cell. Mol. Med., 7, 265-276.
27. Nevinsky, G. A.& Buneva, V. N. Natural catalytic antibodies-abzymes. In E. Keinan, (Eds.), Catalytic antibodies, pp. 503-567. Weinheim: Wiley-VCH Verlag GmbH and Co. KgaA.
28. Kalaga, R., Li, L., O’Dell, J. R.& Paul, S. (1995). Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J. Immunol., 155, 2695-2702.
29. Thiagarajan, P., Dannenbring, R., Matsuura, K., Tramontano, A., Gololobov, G.& Paul, S. (2000). Monoclonal antibody light chain with prothrombinase activity. Biochemistry, 39, 6459-6465.
30. Lacroix-Desmazes, S., Moreau, A., Sooryanarayana, Bonnemain, C., Stieltjes, N., Pashov, A., Sultan, Y., Hoebeke, J., Kazatchkine, M. D.& Kaveri, S. V. (1999). Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat. Med., 5, 1044-1047.
31. Polosukhina, D. I., Kanyshkova, T., Doronin, B. M., Tyshkevich, O. B., Buneva, V. N., Boiko, A. N., Gusev, E. I., Favorova, O. O.& Nevinsky, G. A. (2004). Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J. Cell. Mol. Med., 8, 359-368.
32. Polosukhina D. I., Buneva, V. N., Doronin, B. M., Tyshkevich, O. B., Boiko, A. N., Gusev, E. I., Favorova, O. O.& Nevinsky, G. A. (2005). Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis. Med. Sci. Monit., 11, BR266-BR272.
33. Polosukhina D. I., Kanyshkova, T. G., Doronin, B. M., Tyshkevich, O. B., Buneva, V. N., Boiko, A. N., Gusev, E. I., Favorova, O. O.& Nevinsky, G. A. (2006). Metaldependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. Immunol. Lett., 103, 75-81.
34. Odintsova, E. S., Kharitonova, M. A., Baranovskii, A. G., Siziakina, L. P., Buneva, V. N.& Nevinsky, G. A. (2006). Proteolytic activity of IgG antibodies from blood of acquired immunodeficiency syndrome patients, Biochemistry (Moscow), 71, 251-261.
35. Baranova, S. V., Buneva, V. N., Kharitonova, M. A., Sizyakina, L. P., Calmels, C., Andreola, M. L., Parissi, V.& Nevinsky, G. A. (2009). HIV-1 integrase-hydrolyzing antibodies from sera of HIV-infected patients. Biochimie, 91, 1081-1086.
36. Iverson, B. L.& Lerner, R. A. (1989). Sequence-specific peptide cleavage catalyzed by an antibody. Science, 243, 1184-1188.
37. Ersoy, O., Fleck, R., Blanco, M. J.& Masamune, S. (1999). Design and syntheses of three haptens to generate catalytic antibodies that cleave amide bonds with nucleophilic catalysis. Bioorg. Med. Chem., 7, 279-86.
38. Gao, Q. S.& Paul, S. (1995). Site-directed mutagenesis of antibody-variable regions. Methods Mol. Biol., 51, 319-327.
39. Miller, G. P., Posner, B. A.& Benkovic, S. J. (1997). Expanding the 43C9 class of catalytic antibodies using a chain-shuffling approach. Bioorg. Med. Chem., 5, 581-590.
40. Roberts, V. A., Stewart, J., Benkovic, S. J.& Getzoff, E. D. (1994). Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization. J. Mol. Biol., 235, 1098-1116.
41. Stewart, J. D., Krebs, J. F., Siuzdak, G., Berdis, A. J., Smithrud, D. B.& Benkovic, S. J. (1994). Dissection of an antibody-catalyzed reaction. Proc. Natl. Acad. Sci. USA, 91, 7404-7409.
42. Barbas, C. F., 3rd, Heine, A., Zhong, G., Hoffmann, T., Gramatikova, S., Bjornestedt, R., List, B., Anderson, J., Stura, E. A., Wilson, I. A.& Lerner, R. A. (1997). Immune versus natural selection: antibody aldolases with enzymic rates but broader scope. Science, 278, 2085-2092.
43. Gouverneur, V. E., Houk, K. N., de Pascual-Teresa, B., Beno, B., Janda, K. D.& Lerner, R. A. (1993). Control of the exo and endo pathways of the Diels-Alder reaction by antibody catalysis. Science, 262, 204-208.
44. Janda, K. D., Lo, L. C., Lo, C. H., Sim, M. M., Wang, R., Wong, C. H.& Lerner, R. A. (1997). Chemical selection for catalysis in combinatorial antibody libraries. Science, 275, 945-948.
45. Thayer, M. M., Olender, E. H., Arvai, A. S., Koike, C. K., Canestrelli, I. L., Stewart, J. D., Benkovic, S. J., Getzoff, E. D.& Roberts, V. A. (1999). Structural basis for amide hydrolysis catalyzed by the 43C9 antibody. J. Mol. Biol., 291, 329-345.
46. Slobin, L. I. (1966). Preparation and some properties of antibodies with specificity toward rho-nitrophenyl esters. Biochemistry, 5, 2836-2841.
47. Kul’berg, A. I, Docheva, I. V., Tarkhanova, I. A.& Spivak, V. A. (1969). Proteolytic activity in preparations of purified immunoglobulin G and rabbit antibodies. Biokhimiia (Moscow), 34, 1178-1183.
48. Parkhomenko, T. A., Odintsova, E. S., Buneva, V. N., Kunder, E. V., Zhyltsov, I. V., Senkovich, S. A., Generalov, I. I., Nevinsky, G. A. (2009). DNA-hydrolyzing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections. J. Cell. Mol. Med., 13, 2875-2887.
49. Lacroix-Desmazes, S., Bayry, J., Kaveri, S. V., Hayon-Sonsino, D., Thorenoor, N., Charpentier, J., Luyt, C. E., Mira, J. P., Nagaraja, V., Kazatchkine, M. D., Dhainaut, J. F., Mallet, V. O. (2005). High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc. Natl. Acad. Sci. USA, 102, 4109-4113.
50. Paul, S. (1996). Natural catalytic antibodies. Mol. Biotechnol., 5, 197-207.
51. Paul, S. (1998). Mechanism and functional role of antibody catalysis. Appl. Biochem. Biotechnol., 75, 13-24.
52. Paul, S., Nishiyama, Y., Planque, S., Taguchi, H. (2006). Theory of proteolytic antibody occurrence. Immunol. Lett., 103, 8-16.
53. Tellier, C. (2002). Exploiting antibodies as catalysts: potential therapeutic applications. Transfus. Clin. Biol., 9, 1-8.
54. Zhou, Y. X., Karle, S., Taguchi, H., Planque, S., Nishiyama,& Y. Paul, S. (2002). Prospects for immunotherapeutic proteolytic antibodies. J. Immunol. Methods, 269, 257-268.
55. Nishi, Y. (2003). Enzyme/abzyme prodrug activation systems: potential use in clinical oncology. Curr. Pharm. Des., 9, 2113-2130
56. Stockwin, L.H.& Holmes, S. (2003). Antibodies as therapeutic agents: vive la renaissance! Expert Opin. Biol. Ther. 3, 1133-1152.
57. Hanson, C. V., Nishiyama, Y,& Paul, S. (2005). Catalytic antibodies and their applications. Curr. Opin. Biotechnol., 16, 631-636.
58. Planque, S., Nishiyama, Y., Taguchi, H., Salas, M., Hanson, C.& Paul, S. (2008). Catalytic antibodies to HIV: physiological role and potential clinical utility. Autoimmun. Rev. 7, 473-479.
59. Wójcik, T.& Kieć-Kononowicz, K. (2008). Catalytic activity of certain antibodies as a potential tool for drug synthesis and for directed prodrug therapies. Curr. Med. Chem., 15, 1606-1615.
60. Thiagarajan, P.& Paul, S. (2000). Prothrombin cleaving antibody light chains. Chem. Immunol., 77, 115-129.
61. Taguchi, H., Planque, S., Nishiyama, Y., Symersky, J., Boivin, S., Szabo, P., Friedland, R., P Ramsland, P A. Edmundson, A B. Weksler, M E.& Paul, S. (2008). Autoantibody-catalyzed hydrolysis of amyloid beta peptide. J. Biol. Chem., 283, 4714-4722.
62. Tguchi, H., Planque, S., Nishiyama, Y., Szabo, P.& Weksler, (2008). Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease. Autoimmun Rev., 7, 391-397.
63. Lacroix -Desmazes, S., Misra, N., Bayry, J., Villard, S., Kazatchkine, M. D.& Kaveri, S. V. (2002). Antibodies with hydrolytic activity towards factor VIII in patients with hemophilia A. J. Immunol. Methods, 269, 251-256.
64. Wootla, B., Dasgupta, S., Mallet, V., Kazatchkine, M. D., Nagaraja, V., Friboulet, A., Kaveri, S. V.& Lacroix-Desmazes, S. (2006). Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G. Blood Coagul. Fibrinolysis, 17, 229-234.
65. Lacroix -Desmazes, S., Kazatchkine, M. D.& Kaveri, S. V. (2003). Catalytic antibodies to factor VIII in haemophilia A. Blood Coagul. Fibrinolysis, 14; Suppl. 1, S31-S34.
66. Bayry, J., Lacroix-Desmazes, S., Pashov, A., Stahl, D., Hoebeke, J., Kazatchkine, M. D.& Kaveri, S. V. (2003). Autoantibodies to factor VIII with catalytic activity. Autoimmun. Rev., 2, 30-35.
67. Lacroix-Desmazes, S., Wootla, B., Delignat, S., Dasgupta, S., Nagaraja, V., Kazatchkine, M. D.& Kaveri, S. V. (2006). Pathophysiology of catalytic antibodies. Immunol. Lett., 103, 3-7.
68. Taizo, U., Hifumi, E.& Okamura, Y. (2006). Super catalytic antibodies (antigenase) capable of destroying H. pylori urease. Nippon Rinsho., 64, 286-292.
69. Parren, P. W., Leusen, J. H.& van de Winkel, J. G. (2003). Antibody-catalyzed water oxidation: state-of-the-art immunity or ancient history? Trends Immunol., 24, 467-469.
70. Gabibov, A. G., Kozyr, A. V.& Kolesnikov, A. V. (2000). Disease association and cytotoxic effects of DNA-hydrolyzing autoantibodies. Chem. Immunol., 77, 130-156.
71. Zouali, M. (2001). B cell tolerance to self in systemic autoimmunity. Arch. Immunol. Ther. Exp. (Warsz), 49, 361-365.
72. Pisetsky, D. (2001). Immune response to DNA in systemic lupus erythematosus. Isr. Med. Ass. J. 3, 850-853.
73. Earnshaw, W. C.& Rothfield, N. (1985). Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma. Chromosoma, 91, 313-321.
74. Raptis, L.& Menard, H. A. (1980). Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J. Clin. Invest., 66, 1391-1399.
75. Reimer, C., Raska, I., Tan, E. M.& Sheer, U. (1987). Human autoantibodies: probes for nucleolus structure and function. Virchows. Arch. B Cell Pathol. Incl. Mol. Pathol., 54, 131-36.
76. Gottieb, A. A.& Shwartz, R. H. (1972). Antigen-RNA interactions. Cell Immunol., 5, 341-362.
77. Kubota, T. (1977). Lessons from a monoclonal antibody to double-stranded DNA. J. Med. Dent. Sci., 44, 37-44.
78. Mitsuhashi, S., Saito, R., Kurashige, S.& Yamashugi, N. (1978). Ribonucleic acid in the immune response. Moll. Cell. Biochem., 20, 131-147.
79. Marion, T. N., Krishan, M. R., Desai, D. D., Jou, N. T.& Tillman, D. M. (1997). Monoclonal anti-DNA antibodies: structure, specificity, and biology. Methods, 11, 3-113.
80. Shoenfeld, Y., Ben-Yehuda, O., Messinger, Y., Bentwitch, Z., Rauch, J., Isenberg, D. I., Gadoth, N. (1988). Autoimmune diseases other than lupus share common anti-DNA idiotypes. Immunol. Lett., 17, 285-291.
81. Nevinsky, G. A., Polosukhina, D. I. Doronon, B. M., Tyshkevich, O. B Favorova, O O.& Buneva V. N. (2004). Possible role of Abs hydrolyzing basic myelin protein in pathigenesis and diagnostics of multiple sclerosis. Konsilium (Russ.) 4, 30-34.
82. Hhachn B. Ch. (1996). Systemic lipus erythematosus. In E. E. Braunvald, K.D. Isselbakher, R.G. Petersdorf, D. D., Wilson, D.B. Martin& A.S. Fauchi (Eds.), Internal diseases, pp. 407-419. Moscow: Medicine.
83. Jager, L. (1988). Klinishe immunologie and allergologie, vol. 3, pp. 270
84. VEB Gustav Fischer Verlag.
85. Yee, C. S., Hussein, H., Skan, J., Bowman, S., Situnayake, D.& Gordon C. (2003). Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology, 42, 276-279.
86. Liu, G., Wang, Z., Wang, L., Xie Q., Zhang, R., Zuo, C.& Lin, M. (2002). The correlation between anticardiolipin antibodies and diseases activity in patients with systemic lupus erythematosus Hua Xi Yi Ke Da Xue Xue Bao., 31, 223-225.
87. Korovkina, E. S., Zonova, E. V., Buneva, V. N., Konenkova, L. P.& Nevinsky G. A. (2006). Interdependency analysis between antibody level to different antigenes and clinical data of systemic lupus erythematosus. Allergology and Immunology (Russ.), 7, 498-507.
88. Nasonov, E. L. (1994). Klinics and immunopathology of rheumatic diseases. Moscow: Binom.
89. Dobrovolskii, A. B.& Panchenko E. P. (2002). In V. A. Tkachuk (Eds.), Klinical biochemistry. Moscow: Geotar-medicine.
90. Boger, U., Hegedus, L., Hansen, J. M., Finke, R.& Shleusener, H. (1995). Thyroid cytotoxic antibodies in atrophic and goiters autoimmune thyroiditis. Eur. J. Endocrinol., 132, 69-74.
91. Engler, H., Riesen, W. F.& Keller, B. (1994). Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies. Clin. Chem. Acta., 225, 123-136.
92. Shoenfeld, Y., Teplizki, H. A., Mendlovic, S., Blank, M.& Mozes, E.& Isenberg, D. A. (1989). The role of the human anti-DNA idiotype 16/6 in autoimmunity. Clin. Immunol. Immunopathol., 51, 313-325.
93. Kozyr, A. V., Kolesnikov, A. V., Aleksandrova, E. S., Sashchenko, L. P., Gnuchev, N. V., Favorov, P. V., Kotelnikov, M. A., Iakhnina, E. I., Astsaturov, I. A., Prokaeva, T. B., Alekberova, Z. S., Suchkov, S. V.& Gabibov, A. G. (1998). Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl. Biochem. Biotechnol., 75, 45-61.
94. Gololobov, G. V., Mikhalap, S. V., Starov, A. V., Kolesnikov, A. F.& Gabibov, A. G. (1994). DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies. Appl. Biochem. Biotechnol., 47, 305-314.
95. Sugiama, Y.& Yamamota, T. (1996). Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis. Tohoku J. Exp. med., 178, 203-215.
96. Bigazzi, P. E. (1983). In: S. Cohen, P. E Wozd,& R. T. McKlaskie (Eds), Mechanisms of Immunology, pp. 181-206. Moscow: Meditsina.
97. Founel, S.& Muller, S. (2002). Antinucleosome antibodies and T-cell response in systemic lupus erythematosus. Ann. Med. Interne (Paris), 153, 513-519.
98. Blanco, F., Kalsi, J.& Isenberg, D. A. (1991). Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic diseases. Clin. Exp. Immunol., 86, 66-70.
99. Sato, T., Uvhiumi, T., Arakawa, M.& Kominami, R. (1994). Serological association of lupus autoantibodies to a limited functional domain of 28S ribosomal RNA and to the ribosomal proteins bound to the domain. Clin. Exp. Immunol., 98, 35-39.
100. Hirokawa, K., Takasaki, Y., Takeuchi, K., Kaneda, K., Ikeda, K., Hashimoto, H.& Ikeda, R. (2002). Anti-TS1-RNA: characterization of novel antibodies against sequence-specific RNA by random RNA selection in patients with Sjogren’s syndrome. J. Rheumatol., 29, 931-937.
101. Ikeda, R., Takasaki, Y., Hirokawa, K., Takeuchi, K.& Hashimoto, H. (2003). Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease. J. Rheumatol., 30, 998-1005.
102. Dabelic, N.& Cices, N. (1997). Clinical importance of antinuclear antibodies. Lijec Vjesn., 119, 236-242.
103. O’Connor K C., Bar-Or, A.& Hafler, D. A. (2001). Neuroimmunology of multiple sclerosis. J. Clin. Immunol., 21, 81-92.
104. Archelos, J. J., Storch, M. K.& Hartung, H. P. (2000). The role of B cells and autoantibodies in multiple sclerosis. Ann. Neurol., 47, 694-706.
105. Hemmer, B., Archelos, J. J.& Hartung, H. P. (2002). New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci., 3, 291-301.
106. Niehaus, A., Shi, J., Grzenkowski, M., Diers-Fenger, M., Archelos, J., Hartung, H. P., Toyka, K., Bruck, W.& Trotter, J. (2000). Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination. Ann. Neurol., 48, 362-371.
107. Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A.& Linington, C. (2001). T- and Bcell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia, 36, 220-234.
108. Cross, A. H., Trotter, J. L.& Lyons, J. (2001). B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol., 112, 1-14.
109. Williamson, R. A., Burgoon, M. P., Owens, G. P., Ghausi, O., Leclerc, E., Firme, L., Carlson, S., Corboy, J., Parren, P. W., Sanna, P. P., Gilden, D. H.& Burton, D. R. (2001). Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc. Natl. Acad. Sci. USA, 98, 1793-1798.
110. Ershova, N. A., Garmashova, N.V., Buneva, V. N., (2003). Association between DNA antibodies levels in the blood of patients with multiple sclerosis and clinical presentation of the disease. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova, 2, 25-33.
111. Ershova, N. A., Garmashova, N. V., Mogel nitskii, A S., Tyshkevich, O. B., Doronin, B. M., Konenkova, L. P., Buneva, V. N.& Nevinskii, G. A. (2007). Antibodies to DNA in the blood of patients with multiple sclerosis. Russ. J. Immunol., 1, 229-245.
112. Poser, C. M. (1984). The diagnosis of multiple sclerosis, pp. 3-13. NY: Thieme-Stratton.
113. Polosukhina, D. I., Garmashova, N. V., Tyshkevich, O. B., Doronin, B. M., Buneva, V. N.& Nevinskii, G. A. (2009). Autoantibodies to myelin basic protein in patients with multiple sclerosis. International Journal of Immunorehabilitation (Russ), 11, 10-18.
114. Boiko, A. N.& Favorova O. O. (1995). Multiple sclerosis: molecular and cellular mechanisms. Mol. Biol. (Moscow), 29, 727-749.
115. Gusev, E. I., Demina, T. L.& Boiko, A. N. (1997). Multiple Sclerosis. Moscow: Oil and Gas.
116. Pihlaja, H.& Rantamaki, T. (2003). Linkage disequilibrium between the MBP tetranucleotide repeat and multiple sclerosis is restricted to a geographically defined subpopulation in Finland. Genes and Immunity, 4, 138-146.
117. Andersen, O., Lygner, P. E.& Bergstrom, T. (1993). Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J. Neurol., 240, 417-422.
118. Meinl, E. (1999). Concepts of viral pathogenesis of multiple sclerosis. Curr. Opin. in Neurol., 12, 303-307.
119. Steinman, L. (2001). Multiple sclerosis: a two-stage disease. Nat. Immunol., 2, 2762-2764.
120. Talbot, P. J., Paquette, J. S.& Ciurli C. (1996). Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann. Neurol., 39, 233-240.
121. Klinishe immunologie and allergologie (1988)., Jager L. (Ed.,). Jena, 3, 270-279.
122. Senda, Y., Nishibu, M., Kawai, K., Mizukami, Y.& Hashimoto, T. (1995). Estimation of anti-thyroid peroxidase autoantibody and anti-thyroglobulin autoantibody in patients with various thyroid disease-comparison between histopathological findings and serological results in patients with Hashimoto’s thyroiditis. Rinsho-Byori, 43, 1243-1250.
123. Paul, S., Li, L., Kalaga, R., O’Dell, J., Dannenbring, R. E., Jr., Swindells, S., Hinrichs, S., Caturegli, P.& Rose, N. R. (1997). Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease. J. Immunol., 159, 1530-1536.
124. Garmashova, N. V., Kazanskiĭ, V. E., Tyshkevich, O. B., Doronin, B. M., Buneva, V. N.& Nevinskiĭ, G. A. (2004). Antibodies to DNA in the blood of patients with tickborne encephalitis. Mol. Biol. (Moscow), 38, 723-730.
125. Fauci, A.S., Braunwald, E, Kasper, D.L. et al. (2008). Harrison’s Principles of Internal Medicine, 17th Edition. McGraw-Hill Professional.
126. Matsiota-Bernard, P., Mahana, W., Avrameas, S.& Nauciel, C. (1993). Specific and natural antibody production during Salmonella typhimurium infection in genetically susceptible and resistant mice. Immunology, 79, 375-380.
127. Matsiota-Bernard, P., Hentati, B., Pie, S., Legakis, N., Nauciel, C., Avrameas, S. (1996). Beneficial effect of Salmonella typhimurium infection and of immunoglobulins from S. typhimurium-infected mice on the autoimmune disease of (NZB x NZW) F1 mice. Clin. Exp. Immunol., 104, 228-235.
128. Hentati, B., Sato, M. N., Payelle, B., Avrameas, S.& Ternynck, T. (1994). Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice. Eur. J. Immunol., 24, 8-15.
129. Ternynck, P., Falanga, B., Unterkircher, C., Gregoire, J., Da Silva, L.P.& Avrameas, S. (1991). Induction of high levels of IgG autoantibodies in mice infected with Plasmodium chabaudi. Int. Immunol., 3, 29-37.
130. Unterkircher, C., Avrameas, S.& Ternynck, T. (1993). Autoantibodies in the sera of Trypanosoma cruzi-infected individuals with or without clinical Chagas disease. J. Clin. Lab. Anal., 7, 60-69.
131. Boekel, E. T., Siegert, C. E., Vrielink, G J., Ceelen, A.& De Kievet, W. (2007). Analyses of CD27(++) plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear nntibodies. J. Clin. Immunol., 27, 467-76.
132. Wun, H. L., Leung, D. T., Wong, K. C., Chui, Y. L.& Lim, P. L. (2001). Molecular mimicry: anti-DNA antibodies may arise inadvertently as a response to antibodies generated to microorganisms. Int. Immunol., 13, 1099-1107.
133. Ikehara, S., Kawamura, M.& Takao, F. (1990). Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 87, 8341-8344.
134. Wentworth, P., Jr., Liu, Y., Wentworth, A. D., Fan, P., Foley, M. J.& Janda, K. D. (1998). A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis. Proc. Natl. Acad. Sci. USA, 95, 5971-5975.
135. Jerne, N. K. (1974). Towards a network theory of the immune system. Ann. Immunol. (Paris), 125C, 373-389.
136. Izadyar, L., Friboulet, A., Remy, M. H., Roseto, A.& Thomas, D. (1993). Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity. Proc. Natl. Acad. Sci. USA, 90, 8876-8880.
137. Kolesnikov, A. V., Kozyr, A. V., Alexandrova, E. S., Koralewski, F., Demin, A. V., Titov, M. I., Avalle, B., Tramontano, A., Paul, S., Thomas, D., Gabibov, A. G.& Friboulet, A. (2000). Enzyme mimicry by the antiidiotypic antibody approach. Proc. Natl. Acad. Sci. USA, 97, 13526-13531.
138. Hu, R., Xie, G.Y., Zhang, X., Guo, Z.Q.& Jin, S. (1998). Production and characterization of monoclonal anti-idiotypic antibody exhibiting a catalytic activity similar to carboxypeptidase A. J. Biotechnol., 61. 109-115.
139. Friboulet, A., Izadyar, L., Avalle, B., Roseto, A.& Thomas, D. (1994). Abzyme generation using an anti-idiotypic antibody as the "internal image" of an enzyme active site. Appl. Biochem. Biotechnol., 47, 229-237.
140. Debat, H., Avalle, B., Chose, O., Sarde, C.-O., Friboulet, A., Thomas, D. (2001). Overpassing an aberrant V(kappa) gene to sequence an anti-idiotypic abzyme with (beta)-lactamase-like activity that could have a linkage with autoimmune diseases. FASEB J., 15, 815-822.
141. Hifumi, E., Morihara, F., Hatiuchi, K., Okuda, T., Nishizono, A.& Uda, T. (2008). Catalytic features and eradication ability of antibody light-chain UA15-L against Helicobacter pylori. J. Biol. Chem., 283, 899-907.
142. Shuster, A. M., Gololobov, G. V., Kvashuk, O. A.& Gabibov, A. G. (1991). DNAspecific catalytic antibodies in human blood sera. Dokl. Akad. Nauk SSSR, 318, 1262-1264.
143. Gabibov, A. G., Gololobov, G. V., Makarevich, O. I., Schourov, D. V., Chernova, E. A.& Yadav, R. P. (1994). LND hydrolyzing autoantibodies. Appl. Biochem. Biotechnol., 47, 293-302.
144. Odintsova, E. S., Buneva, V. N.& Nevinsky, G. A. (2005). Casein-hydrolyzing activity of sIgA antibodies from human milk. J. Mol. Recognit., 18, 413-421.
145. Bronshtein, I. B., Shuster, A. M., Gololobov, G. V., Gromova, I. I., Kvashuk, O. A., Belostotskaya, K. M., Alekberova, Z. S., Prokaeva, T. B.& Gabibov, A. G. (1992). DNA-specific antiidiotypic antibodies in the sera of patients with autoimmune diseases. FEBS Lett., 314, 259-263.
146. Crespeau, H., Laouar, A.& Rochu, D. (1994). Polyclonal DNase abzyme produced by anti-idiotypic internal image method. CR Acad. Sci III., 317, 819-823.
147. Krasnorutskii, M. A., Buneva, V. N,& Nevinsky, G. A. (2008). Antibodies against DNA hydrolyze DNA and RNA. Biochemistry (Moscow), 73, 1547-1560.
148. Krasnorutskii, M. A., Buneva, V. N.& Nevinsky, G. A. (2008). Antibodies against RNA hydrolyze RNA and DNA. J. Mol. Recognit., 21, 337-346.
149. Krasnorutskii, M. A., Buneva, V. N.& Nevinsky, G. A. (2008). Immunization of rabbits with DNase I produces polyclonal antibodies with DNase and RNase activities. J. Mol. Recognit., 21, 233-242.
150. Krasnorutskii, M. A., Buneva, V. N.& Nevinsky G. A. (2008). Anti-RNase Antibodies against pancreatic ribonuclease A hydrolyze RNA and DNA. Int. Immunol., 20, 1031-1040.
151. Krasnorutskii, M. A., Buneva, V. N.& Nevinsky, G. A. (2009). Immunization of rabbits with DNase II leads to formation of polyclonal antibodies with DNase and RNase activities. Int. Immunol., 21, 349-360.
152. Nishi, Y. (2002). Evolution of catalytic antibody repertoire in autoimmune mice. J. Immunol. Methods, 269, 213-233.
153. Tawfik, D. S., Chap, R., Green, B. S., Sela, M.& Eshhar, Z. (2002). Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity? Proc. Natl. Acad. Sci. USA, 92, 2145-2149.
154. Buneva, V. N., Kudryavtseva, A. N., Gal’vita, A. V., Dubrovskaya, V. V., Khokhlova, O. V., Kalinina, I. A., Galenok, V. A.& Nevinsky, G. A. (2003). Dynamics of antibody nuclease activity in blood of women during pregnancy and lactation. Biochemistry (Moscow), 68, 890-900.
155. Savel’ev, A. N., Kanyshkova, T. G., Kulminskaya, A. A., Buneva, V. N., Eneyskaya, E. V., Filatov, M. V., Nevinsky, G. A.& Neustroev, K. N.(2001). Amylolytic activity of IgG and sIgA immunoglobulins from human milk. Clin. Chim. Acta, 314, 141-152.
156. Kanyshkova, T. G., Semenov, D. V., Khlimankov, D., Buneva, V. N.& Nevinsky, G. A. (1997). DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers. FEBS Lett., 416, 23-26.
157. Nevinsky, G. A., Kanyshkova, T. G., Semenov, D. V., Vlassov, A. V., Gal’vita, A. V.& Buneva, V. N. (2000). Secretory immunoglobulin A from healthy human mothers’ milk catalyzes nucleic acid hydrolysis. Appl. Biochem. Biotechnol., 83, 115-129.
158. Buneva, V. N., Kanyshkova, T. G., Vlassov, A. V., Semenov, D. V., Khlimankov, D., Breusova, L. R.& Nevinsky, G. A. (1998). Catalytic DNA- and RNA-hydrolyzing antibodies from milk of healthy human mothers. Appl. Biochem. Biotechnol., 75, 63-76.
159. Semenov, D. V., Kanyshkova, T. G., Kit, Y. Y., Khlimankov, D. Y., Akimzhanov, A. M., Gorbunov, D. A., Buneva, V. N.& Nevinsky, G. A. (1998). Human breast milk immunoglobulins G hydrolyze nucleotides. Biochemistry (Moscow), 63, 944-951.
160. Nevinskii, G. A., Kanyshkova, T. G., Semenov, D. V.& Buneva, V. N. (2001). Catalytically active antibodies and their expected biological function. Vestn. Ross. Akad. Med. Nauk, 2, 38-45.
161. Semenov, D. V., Kanyshkova, T. G., Karotaeva, N. A., Krasnorutskii, M. A., Kuznetsova, I. A., Buneva, V. N.& Nevinsky, G. A. (2004). Catalytic nucleotidehydrolyzing antibodies in milk and serum of clinically healthy human mothers. Med. Sci. Monit., 10, BR23-BR33.
162. Kit, Yu., Semenov, D.& Nevinskii, G. A. (1995). Do catalytically active antibodies exist in healthy people? Mol. Biol. (Moscow), 29, 893-906.
163. Kit, Yu.Ya., Semenov, D. V.& Nevinsky, G. A. (1996). Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin A. Biochem. Mol. Biol. Int., 39, 521-527.
164. Nevinsky, G. A., Kit, Y., Semenov, D. V., Khlimankov, D.& Buneva, V. N. (1998). Secretory immunoglobulin A from human milk catalyses milk protein phosphorylation. Appl. Biochem. Biotechnol., 75, 77-91.
165. Gorbunov, D. A., Semenov, D. V., Shipitsin, M.V.& Nevinsky, G. A. (2001). Unusual phospholipids of human breast milk. Dokl. Biochem. Biophys., 377, 62-64.
166. Gorbunov, D. V., Semenov, D. V., Shipitsin, M. V., Kit, Yu. Yu., Kanyshkova, T. G., Buneva, V. N.& Nevinsky, G. A. (2000). Phosphorylation of minor lipids of human milk tightly bound to secretory immunoglobulin A. Rus. J. Immunol., 5, 267-278.
167. Gorbunov, D. V., Karataeva, N. A., Buneva, V. N.& Nevinsky, G. A. (2005). Lipid kinase activity of antibodies from milk of clinically healthy human mothers. Biochim. Biophys. Acta, 1735, 153-166.
168. Karataeva, N. A., Gorbunov, D., Prokudin, I. V., Buneva, V. N., Kulminskaya, A. A., Neustroev, K. N.& Nevinsky, G. A. (2006). Human milk antibodies with polysaccharide kinase activity. Immunol. Lett., 103, 58-67.
169. Karataeva, N. A., Buneva, V. N.& Nevinsky, G. A. (2006). Polysaccharide kinase activity of human milk IgG antibodies. Biochemistry (Moscow), 71, 1488-1504.
170. Karataeva, N. A.& Nevinsky, G. A. (2007). Enzymes phosphorylating lipids and polysaccharides. Biochemistry (Mosc), 72, 367-379.
171. Amino, N., Mori, H., Iwatani, Y., Tanizawa, O., Kawashima, M., Tsuge, I., Ibaragi, K., Kumahara, Y.& Miyai, K. (1982). High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N. Engl. J. Med., 306, 849-852.
172. Tanaka, A., Lindor, K., Ansari, A.& Gershwin, M. E. (2000). Fetal microchimerisms in the mother: immunologic implications. Liver Transpl., 6, 138-143.
173. Dayan, C. M.& Daniels, G. H. (1996). Chronic autoimmune thyroiditis. New Engl. J. Med., 335, 99-107.
174. Freeman, R., Rosen, H.& Thysen, B. (1986). Incidence of thyroid dysfunction in an unselected post-partum population. Arch. Intern. Med., 146, 1361-1364.
175. Fey, H. R., Burtler, R.& Marti, F. (1973). The production in the pregnant cow of antihuman immunoglobulin to be used for the antiglobulin test. Vox Sang, 25, 245-253.
176. Mestecky, J.& McGhee, J. R. (1987). Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol., 40, 153-245.
177. Kazakov, V. I., Bozhkov, V. M., Linde V. A., Repina, M. A., Mikhailov, V. M. (1995). Extracellular DNA of pregnant women blood. Tsitologiia (Moscow), 37, 232-235.
178. Newman, J. (1995). How breast milk protects newborns. Sci. Am., 273, 76-79.
179. Mikhailov, V. M., Linde, V. A., Rozanov, I. M., Kottsova, N. A., Susloparov, L. A.& Konycheva, E. A. (1992). DNA synthesis and content in human decidual cells at different stages of differentiation based on flow cytometry data. Tsitologiia (Moscow), 34, 67-71.
180. Redhead, K., Hill, T.& Mulloy, B. (1990). Antimicrobial effect of human milk on Bordetella pertussis. FEMS Microbiol Let., 58, 269-273.
181. Gillin, F. D., Reiner, D. S.& Wang, C. S. (1983). Human milk kills parasitic intestinal protozoa. Science, 221, 1290-1292.
182. Nagata, S.& Suda, T. (1995). Fas and Fas ligand: lpr and gld mutations. Immunol. Today, 16, 39-43.
183. Watanabe-Fukunada, R., Brannan, C. I.& Copeland, N. G. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356, 314-317.
184. Ponomarenko, N. A., Durova, O. M., Vorobiev, I. I., Telegin, G. V., Chamborant, O. G., Sidorik, L. L., Suchkov, S. V., Alekbarova, Z. S., Gnuchev, N. V.& Gabibov, A. G. (2002). Catalytic antibodies in clinical and experimental pathology: human and mouse models. J. Immunol. Methods, 269, 197-221.
185. Mouratou, B., Rouyre, S.& Guedson, J. L. (2002). A method for the detection and screening of catalytic anti-DNA antibodies. J. Immunol. Methods, 269, 147-155.
186. Kim, J. S., Lee, S. Y., Lee, W. R., Sohn, J. N., Chung, Y. C., Shim, H. K., Lee, S. C., Kwon, M. H.& Kim, Y. S. (2006). Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity. J. Biol. Chem., 281, 15287-15295.
187. Dubrovskaya, V. V., Andryushkova, A. S., Kuznetsova, I. A., Toporkova, L. B., Buneva, V. N., Orlovskaya, I. A.& Nevinsky, G. A. (2003). DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice. Biochemistry (Moscow), 68, 1081-1088.
188. Andryushkova, A. A., Kuznetsova, I. A., Orlovskaya, I. A., Buneva, V. N.& Nevinsky, G. A. (2006). Antibodies with amylase activity from the sera of autoimmune-prone MRL/MpJ-lpr mice. FEBS Lett., 580, 5089-5095.
189. Andryushkova, A. S., Kuznetsova, I. A., Orlovskaya, I. A., Buneva, V. N.& Nevinsky, G. A. (2009). Nucleitide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice. Int. immunol., 21, 935-945.
190. Andryushkova, A. S., Kuznetsova, I. A., Buneva, V. N., Toporkova, L. B., Sakhno, L. V., Tichonova, M. A., Chernykh, E. R., Orlovskaya, I. A.& Nevinsky, G. A. (2007). Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoetic progenitors. J. Cell. Mol. Med., 11, 531-551.
191. Hanson, L. A., Carlsson, B.& Cruz, J. R. (1979). Colostrum-derived immunity and maternal–neonatal interaction, pp. 145-157. In: P. L Ogra and D. H. Dayton (Eds.), Immunology of Breast milk. New York: Raven Press.
192. Roux, M. E., McWilliams, M., Phillips-Quagliata, J. M., Weisz-Carrington, P.& Lamm, M. E. (1977). Origin of IgA-secreting plasma cells in the mammary gland. J. Exp. Med., 146, 1311-1322.
193. Butcher, E. C., Rouse, R. V., Coffman, R. L., Nottenburg, C. N., Hardy, R. R.& Weissman, I. L. (1982). Surface phenotype of Peyer’s patch germinal center cells: implications for the role of germinal centers in B cell differentiation. J. Immunol., 129, 2698-2707.
194. Brandtzaeg, P., Farstad, I.N., Johansen, F. E., Morton, H. C., Norderhaug, I. N.& Yamanaka, T. (1999). The B-cell system of human mucosae and exocrine glands. Immunol. Rev., 171, 45-87.
195. Kim, K., Keller, M. A.& Heiner, D. C. (1992). Immunoglobulin G subclasses in human colostrum, milk, and saliva. Acta Paediatr., 81, 113-118.
196. Galvita, A. V., Baranovskii, A. G. Kuznetsova, I. A., Vinshu, N. V., Galenok, V. A., Buneva, V. N.& Nevinsky G. A. (2007). A peculiarity of DNA hydrolysis by antibodies from patients with diabetes. Russ. J. Immunol., 1, 116-131.
197. Odintsova, E. S., Parkhomanko, T. A., Buneva, V. N., Generalov, I. I.& Nevinsky, G. A. (2006). IgG antibodies from the sera of patients with some infectional diseases. Immunopathology. Allergology and Infectology (Russian), 2, 23-31.
198. Sun, M., Li, L., Gao, Q. S., Paul, S. (1994). Antigen recognition by an antibody light chain. J. Biol. Chem., 269, 734-738.
199. Sun, M., Gao, Q. S., Kirnarskiy, L., Rees, A., Paul, S. (1997). Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain. J. Mol. Biol., 271, 374-385.
200. Mei, S., Mody, B., Eklund, S. H., Paul, S. (1991). Vasoactive intestinal peptide hydrolysis by antibody light chains. J. Biol. Chem., 266, 15571-15574.
201. Tyutyulkova, S., Gao, Q. S., Thompson, A., Rennard, S., Paul, S. (1996). Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display. Biochim. Biophys. Acta, 1316, 217-223.
202. Andrievskaya, O. A., Buneva, V. N., Naumov, V. A.& Nevinsky, G. A. (2000). Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus. Med. Sci. Monit., 6, 460-470.
203. Andrievskaya, O. A., Buneva, V. N., Baranovskii, A. G., Gal’vita, A. V., Benzo, E. S., Naumov, V. A.& Nevinsky, G. A. (2002). Catalytic diversity of polyclonal RNAhydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. Immunol. Lett., 81, 191-198.
204. Baranovskii, A. G., Ershova, N. A., Buneva, V. N., Kanyshkova, T. G., Mogelnitskii, A. S., Doronin, B. M., Boiko, A. N., Gusev, E. I., Favorova, O. O.& Nevinsky, G. A. (2001). Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol Lett., 76, 163-167.
205. Wentworth, P. Jr., Jones, L. H., Wentworth, A. D., Zhu, X., Larsen, N. A., Wilson, I. A., Xu, X., Goddard, W. A. 3rd, Janda, K. D., Eschenmoser, A.& Lerner, R. A. (2001). Antibody catalysis of the oxidation of water. Science, 293, 1806-1811.
206. Wentworth, A. D., Jones, L. H., Wentworth, P. Jr., Janda, K. D., Lerner, R. A. (2000). Antibodies have the intrinsic capacity to destroy antigens. Proc. Natl. Acad. Sci. USA, 97, 10930-10935.
207. Ikhmyangan, E. N., Vasilenko, N. L., Buneva, V. N.& Nevinsky, G. A. (2005). IgG antibodies with peroxidase-like activity from the sera of healthy Wistar rats. FEBS Lett., 579, 3960-3964.
208. Ikhmyangan, E. N., Vasilenko, N. L., Buneva, V. N.& Nevinsky, G. A. (2006). Metal ions-dependent peroxidase and oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats. J. Mol. Recognit., 19, 91-105.
209. Ikhmyangan, E. N., Vasilenko, N. L., Sinitsina, O. I., Buneva, V. N.& Nevinsky, G. A. (2006). Substrate specificity of rat sera IgG antibodies with peroxidase and oxidoreductase activities. J. Mol. Recognit., 19, 432-440.
210. Ikhmyangan, E. N., Vasilenko, N. L., Sinitsina, O. I., Buneva, V. N.& Nevinsky, G. A. (2006). Catalytic heterogeneity of immunoglobulins G with peroxidase activity derived from blood of healthy Wistar rats. Immunopathology, Allergology, Infectology (Russian), 2, 32-48.
211. Golinelli-Pimpaneau, B., Gigant, B., Bizebard, T., Nazava, J., Saludjian, P., Zemel, R., Tawfik, D. S., Eshhar, Z., Green, B. S.& Knossow, M. (1994). Crystal structure of catalytic antibody Fab with esterase-like activity. Current Biology, Structure, 2, 175-183.
212. Legostaeva, G. A., Polosukhina, D. I., Bezuglova, A. M., Doronin, B. M. Buneva, V. N.& Nevinsky, G. A. (2010) Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis. J. Cell Mol. Med., 14, 699-709.
213. Baranovskii, A. G., Matushin, V. G., Vlassov, A. V., Zabara, V. G., Naumov, V. A., Buneva, V. N., Nevinskii, G. A. (1997). DNA- and RNA-hydrolyzing antibodies from the blood of patients with various forms of viral hepatitis. Biochemistry (Moscow), 62, 1358-1366.
214. Fersht, A. (1985). Enzyme Structure and Mechanism, 2nd ed. N.Y.: W. H. Freeman, Co.
215. Dixon, M.& Webb, E. C. (1979). Enzymes, Third addition, Longman Group Ltd.
216. Vlassov, A. V., Andrievskaya, O. A., Kanyshkova, T. G., Baranovsky, A. G., Naumov, V. A., Breusov, A. A., Giege, R., Buneva, V. N.& Nevinsky, G. A. (1997). RNAhydrolyzing antibodies from peripheral blood of patients with lupus erythematosus, Biochemistry (Moscow). 62, 474-479.
217. Vlasov, A. V., Baranovskii, A. G., Kanyshkova, T. G., Prints, A. V., Zabara, V. G., Naumov, V. A., Breusov, A. A., Giege R., Buneva, V. N.& Nevinskii, G. A. (1998). Substrate specificity of serum DNA- and RNA-hydrolyzing antibodies of patients with polyarthritis and autoimmune thyroiditis. Mol. Biol. (Mosk), 32, 559-569.
218. Vlassov, A, Florentz, C., Helm, M., Naumov, V, Buneva, V, Nevinsky, G.& Giege, R. (1998). Characterization and selectivity of catalytic antibodies from human serum with RNAse activity. Nucleic Acid Research, 26, 5243-5250.
219. Vlassov, A. V., Helm, M., Florentz, C., Naumov, V., Breusov, A. A. Buneva V. N, Giege, R.& Nevinsky, G. A. (1999). Variability of substrate specificity of serum antibodies obtained from patients with different autoimmune and viral deseases in reaction of tRNA hydrolysis. Russ. J. Immunol., 4, 25-32.
220. Vlasov, A. V., Helm, M., Naumov, V. A., Breusov, A. A., Buneva, V. N., Florentz, C., Giege, R.& Nevinskii, G. A. (1999). Features of tRNA hydrolysis by autoantibodies from blood serum of patients with certain autoimmune and virus diseases. Mol. Biol. (Moscow), 33, 866-872.
221. Andrievskaia, O. A., Kanyshkova, T. G., Iamkovoi, V. I., Buneva, V. N.& Nevinskii, G. A. (1997). Monoclonal antibodies to DNA hydrolyze RNA better than DNA. Dokl. Akad. Nauk, 355, 401-403.
222. Komoda, T., Koyama, I., Hasegawa, M.& Sakagishi, Y. (1983). Alkaline phosphatase - with special reference to alkaline phosphatases of the blood cells. Rinsho Byori, 31, 682-691.
223. Hardonk, M. J.& Koudstaal, J. (1976). Enzyme histochemistry as a link between biochemistry and morphology. Prog. Histochem. Cytochem., 8, 1-68.
224. Berneman, A., Cuilbert, B., Enschrich, S.& Avrames, S. (1993). IgG auto- and polyreactivities of normal human sera. Mol. Immunol., 30, 1499-1510.
225. Coutinho, A., Kazatchkine, M. D.& Avrameas, S. (1995). Natural autoantibodies. Curr. Opin. Immunol., 7, 812-818.
226. Raz, E., Ben-Bassat, H., Davidi, T., Shlomoz, Z.& Eilat, D. (1993). Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Eur. J. Immunol., 23, 383-390.
227. Gololobov, G. V., Chernova, E. A., Schourov, D. V., Smirnov, I. V., Kudelina, I. A.& Gabibov, A. G. (1995). Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. Proc. Natl. Acad. Sci. USA, 92, 254-257.
228. Baranovskii, A. G., Kanyshkova, T. G., Mogelnitskii, A. S., Naumov, V. A., Buneva, V. N., Gusev, E. I., Boiko, A. N., Zargarova, T. A., Favorova, O. O.& Nevinsky, G. A. (1998). Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Moscow). 63, 1239-1248.
229. Andrievskaia, O. A., Buneva, V. N., Zabara, V. G., Naumov, V. A., Iamkovoi, V. I.& Nevinskii, G. A. (1998). Class M immunoglobulins from blood serum of patients with systemic lupus erythematosus effectively cleave RNA. Mol. Biol. (Moscow), 32, 908-915.
230. Akagi, K., Murai, K., Hirao, N.& Yamanaka, M. (1976). Purification and properties of alkaline ribonucleases from human serum. Biochim. Biophys. Acta, 442, 368-378.
231. Kuznetsova, I. A., Orlovskaya, I. A., Buneva, V. N.& Nevinsky, G. A. (2007). Activation of DNA-hydrolyzing antibodies from the sera of autoimmune-prone MRLlpr/lpr mice by different metal ions. Biochim. Biophys. Acta, 1774, 884-896.
232. Paul, S., Mei, S., Mody, B., Eklund, S. H., Beach, C. M., Massey, R. J.& Hamel, F. (1991). Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies. J. Biol. Chem., 266, 16128-16134.
233. Paul, S., Karle, S., Planque, S., Taguchi, H., Salas, M., Nishiyama, Y., Handy, B., Hunter, R., Edmundson, A,& Hanson, C. (2004). Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp 120. J. Biol. Chem., 279, 30611-39619.
234. Ponomarenko, N. A., Durova, O. M., Vorobiev, I. I., Belogurov, A. A., Kurkova, I. N., Petrenko, A. G., Telegin, G. B., Suchkov, S. V., Kiselev, S. L., Lagarkova, M. A., Govorun, V. M., Serebryakova, M. V., Avalle, B., Tornatore, P., Karavanov, A., Thomas, D., Friboulet, A.& Gabibov, A. G. (2006). Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc. Natl. Acad. Sci. USA, 103, 281-286.
235. Savel’ev, A. N., Eneyskaya, E. V., Shabalin, K. A., Filatov, M. V.& Shabalin, K. A., (1999). Autoantibodies with amylolytic activity. Prot. Pept. Lett., 6, 179-184.
236. Ivanen, D. R., Kulminskaya, A. A., Shabalin, K. A., Isaeva-Ivanova, L. V., Ershova N. A., Saveliev, A. N., Nevinsky, G. A.& Neustroev, K. N. (2004). Catalytic properties of IgMs with amylolytic activity isolated from patients with multiple sclerosis. Med. Sci. Monit., 10, BR273-BR280.
237. Neustoev, K. N., Ivanen, D. R., Kulminskaya, A. A., Brumer, I. H., Saveliev, A. N.& Nevinsky, G. A. (2003). Amylolytic activity and catalytic properties of IgM and IgG antibodies from patients with systemic lupus erythematosus. Human antibodies, 12, 31-34.
238. Savel’iev, A. N., Ivanen, D. R., Kulminskaya, A. A., Ershova, N. A., Kanyshkova, T. G., Buneva, V. N., Mogelnitskii, A. S., Doronin, B. M., Favorova, O. O.& Nevinsky, G. A.& Neustroev, K. (2003). Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol. Lett., 86, 291-297.
239. Gololobov, G. V., Rumbley, C. A., Rumbley, J. N., Schourov, D. V., Makarevich, O. I., Gabibov, A. G., Voss, E. W., Jr.& Rodkey, L. S. (1997). DNA hydrolysis by monoclonal anti-ssDNA autoantibody BV 04-01: origins of catalytic activity. Mol. Immunol., 34, 1083-1093.
240. Kasho, V. N.& Baykov, A. A. (1989). Two pathways for phosphate/water oxygen exchange by yeast inorganic pyrophosphatase. Biochem. Biophys. Res. Commun., 161, 475-480.
241. Shestakov, A. A., Baykov, A. A.& Avaeva, S. M. (1990). Tightly bound pyrophosphate in Escherichia coli inorganic pyrophosphatase. FEBS Lett., 262, 194-196.
242. Smirnova, I. N., Shestakov, A. S., Dubnova, E. B.& Baykov, A. A. (1989). Spectral and kinetic studies of phosphate and magnesium ion binding to yeast inorganic pyrophosphatase. Eur. J. Bioche., 182, 451-456.
243. Tolmacheva, A. S., Zaksas, N. P., Buneva, V. N., Vasilenko, N. L.& Nevinsky, G. A. (2009). Oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats are better activated by combinations of different metal ions. J. Mol. Recognit., 22, 26-37.
244. Sorrentino, S.& Libonaty, M. (1994). Human pancreatic-type and nonpancreatic-type ribonucleases: a direct side-by -side comparison of their catalytic properties. Biochemistry, 312, 340-344.
245. Sorrentino, S.& Libonaty, M. (1997). Structure-function relationships in human ribonucleases: main distinctive features of the major RNase types. FEBS Lett., 404, 1-5.
246. Horl, W. H., Wanner, C.& Schollmer, P. (1987). Proteinases in catabolism and malnutrition. JPEN J. Parenter. Enteral Nutr., 11, 98S-103S.
247. Rao, M. B., Tanksale, A. M., Ghatge, M. S.& Deshhange, V. V. (1998). Molecular and biotechnological aspects of microbial proteases. Microbiol. Mol. Biol. Rev., 62, 597-635.
248. Bernardi, G. (1971). In Boyer, P.D. (Eds.), The enzymes. New York: Academic Press.
249. Suck, D. (1994). DNA recognition by DNase I. J. Mol. Recognit., 7, 65-70.
250. Odintsova, E. S., Kharitonova, M. A., Baranovskii, A. G., Siziakina, L. P., Buneva, V. N.& Nevinskii, G. A. (2006). DNA-hydrolyzing IgG antibodies from the blood of patients with acquired immune deficiency syndrome. Mol. Biol. (Moscow), 40, 857-864.
251. Shapot, V. S. (1968). Nucleases, pp. 1-162. Moscow; Medicine Press.
252. Sierakowska, H.& Shugar, D. (1977). Mammalian nucleolytic enzymes. Progr. Nucleic Acid Res. Mol. Biol., 20, 59-130.
253. Akagi, K., Yamanaka, M., Murai, K.& Omae, T. (1978). Purification and properties of acid ribonucleases in humam serum and leukocytes. Cancer Res., 38, 2163-2167.
254. Sorrentino, S., Libonaty, M. (1994). Human pancreatic-type and nonpancreatic-type ribonucleases: a direct side-by-side comparison of their catalytic properties. Arch. Biochem. Biophys., 312, 340-348.
255. Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A.& Klinman, D. M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546-549.
256. Gilkeson, G. S., Grudier, J. P., Karounos, D. G.& Pisetsky, D. S. (1989). Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J. Immunol., 151, 1614-1626.
257. Fletcher, M. C., Kuderova, A., Cygler M.& Lee, J. S. (1998). Creation of a ribonuclease abzyme through site-directed mutagenesis. Nat. Biotechnol., 16, 1065-1067.
258. Paul, S. (1994). Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies. Appl. Biochem. Biotechnol., 47, 241-253.
259. Paul, S., Said, S. I., Thompson, A. B., Volle, D. J., Agrawal, D. K., Foda, H.& de la Rocha, S. (1989). Characterization of autoantibodies to vasoactive intestinal peptide in asthma. Characterization of autoantibodies to vasoactive intestinal peptide in asthma. J. Neuroimmunol., 23, 133-142.
260. Belogurov, A. A., Kurkova, I. N., Friboulet, A., Thomas, D., Misikov, V. K., Zakharova, M. Y., Suchkov, S. V., Kotov, S. V., Alehin, A. I., Avalle, B., Suslova, E. A., Morse III H. C., Gabibov, A. G,& Ponomarenko, N. A. (2008). Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J. Immunol., 180, 1258-1267.
261. Kozyr, A. V., Sashchenko, L. P., Kolesnikov, A. V., Zelenova, N. A., Khaidukov, S. V., Ignatova, A. N., Bobik, T. V., Gabibov, A. G., Alekberova, Z. S., Suchkov, S. V.& Gnuchev, N. V. (2002). Immunol. Lett., 80, 41-47.
262. Sinohara, H.& Matsuura, K. (2000). Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma? Appl. Biochem. Biotechnol., 83, 85-94.
263. Nevinsky, G. A., Breusov, A. A., Baranovskii, A. G., Prints, A. V., Kanyshkova, T. G., Galvita, A. V., Naumov, V. A.& Buneva, V. N. (2001). Effect of different drugs on the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto‘s thyroiditis and nontoxic nodal goiter. Med. Sci. Monit., 7, 201-211.
264. Breusov, A. A., Gal vita, A. V., Benzo, E. S., Baranovskii, A. G., Prints, A. V., Naumov, V. A., Buneva, V. N.& Nevinsky, G. A. (2001). Comparison of the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto‘s thyroiditis and nontoxic nodal goiter. Rus. J. Immunol., 6, 17-28.
265. Li, L., Paul, S., Tyutyulkova, S., Kazatchkine, M. D.& Kaveri, S. (1995) Catalytic activity of anti-thyroglobulin antibodies. J. Immunol., 154, 3328-3332.
266. Ivanen, D. R., Kulminskaya, A. A., Eneyskaya, E. V., Ershova N. A., Shabalin, K. A., Savel ev, A. N., Kanyshkova, T. G., Buneva V. N., Nevinsky G. A.& Neustroev, K. N. (2002). Human autoantibodies with amylolytic activity. Biologia (Bratislava), 57, suppl. 11, 253-260.
267. Savel ev, A. N., Kulminskaya, A. A., Ivanen, D. R., Nevinsky G. A.& Neustroev, K. N. (2004). Human antibodies with amylolytic activity. Trends in Glycoscience and Glycotechnology, 16, 17-31.
268. Tomasi, T. B. (1979). Introduction In P. L. Ogra,& D. H. Dayton (Eds.), Immunology of Breast milk. New York: Raven Press.
269. Fiat, A. M.& Jolles, P. (1989). Caseins of various origins and biologically active casein peptides and oligosaccharides: structural and physiological aspects. Mol. Cell. Biochem., 87, 5-30.
270. Brambell, F. W. (1970). The transmission of passive immunity from mother to young. Amsterdam: North-Holland.
271. Ramaswamy, H., Swamy, C. V.& Das, M. R. (1993). Purification and characterization of a high molecular weight ribonuclease from human milk. J. Biol. Chem., 268, 4181-4187.
272. Wiegandt, H. (1985). Glycolipids. Amsterdam: Elsevier.
273. Meyer zu Heringdorf D., van Koppen, C. J.& Jacobs, K. H. (1997). Molecular diversity of sphingolipids signalling. FEBS Lett., 410, 34-38.
274. Kates, M. (1972). Techniques of lipidology. New York: Elsivier.
275. Jensen, R.G. (1989). The lipids of human milk, pp. 65-92. Boca Raton, Fla: CRC Press.
276. Coppa, G. V., Bruni, S., Morelli, L., Soldi, S.& Gabrielli, O. (2004). The first prebiotics in humans: human milk oligosaccharides. J. Clin. Gastroenterol., 38, (6 Suppl), S80-S83.
277. Newburg, D.S. (1999). Human milk glycoconjugates that inhibit pathogens. Curr. Med. Chem., 6, 117-127.
278. De Prada, P., Winger, G.& Landry, D. W. (2000). Application of artificial enzymes to the problem of cocaine. Ann. N.Y. Acad. Sci., 909, 159-169.
279. Ponomarenko, N. A., Vorobiev, I. I., Alexandrova, E. S., Reshetnyak, A. V., Telegin, G. B., Khaidukov, S. V., Avalle, B., Karavanov, A., Morse, III H. C., Thomas, D., Friboulet, A.& Gabibov, A. G. (2006). Induction of a protein-targeted catalytic response in autoimmune prone mice: antibody-mediated cleavage of HIV-1 glycoprotein GP 120. Biochemistry, 45, 324-330.